Abstract
Heparin and low molecular weight heparins are major clinical anticoagulants and the drugs of choice for the treatment of deep venous thrombosis. The discovery of an antithrombin binding domain in heparin focused interest on understanding the mechanism of heparins antithrombotic / anticoagulant activity. Various heparin-mimetic oligosaccharides have been prepared in an effort to replace polydisperse heparin and low molecular weight heparins with a structurally-defined anticoagulant. The goal of attaining a heparin-mimetic with no unwanted side-effects has also provided motivation for these efforts. This article reviews structure-activity relationship (SAR) of structurally-defined heparin-mimetic oligosaccharides.
Keywords: heparin, anticoagulant, antithrombotic, antithrombin III, heparin pentasaccharide, factor xa, thrombin, bisaldonic acid amides
Current Pharmaceutical Design
Title: Synthetic Oligosaccharides as Heparin-Mimetics Displaying Anticoagulant Properties
Volume: 9 Issue: 28
Author(s): Fikri Y. Avci, Nathalie A. Karst and Robert J. Linhardt
Affiliation:
Keywords: heparin, anticoagulant, antithrombotic, antithrombin III, heparin pentasaccharide, factor xa, thrombin, bisaldonic acid amides
Abstract: Heparin and low molecular weight heparins are major clinical anticoagulants and the drugs of choice for the treatment of deep venous thrombosis. The discovery of an antithrombin binding domain in heparin focused interest on understanding the mechanism of heparins antithrombotic / anticoagulant activity. Various heparin-mimetic oligosaccharides have been prepared in an effort to replace polydisperse heparin and low molecular weight heparins with a structurally-defined anticoagulant. The goal of attaining a heparin-mimetic with no unwanted side-effects has also provided motivation for these efforts. This article reviews structure-activity relationship (SAR) of structurally-defined heparin-mimetic oligosaccharides.
Export Options
About this article
Cite this article as:
Avci Y. Fikri, Karst A. Nathalie and Linhardt J. Robert, Synthetic Oligosaccharides as Heparin-Mimetics Displaying Anticoagulant Properties, Current Pharmaceutical Design 2003; 9 (28) . https://dx.doi.org/10.2174/1381612033453929
DOI https://dx.doi.org/10.2174/1381612033453929 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice
Current Alzheimer Research Voltage-Gated Sodium Channels and Pain
Current Drug Targets - CNS & Neurological Disorders Prediction Models based on miRNA-disease Relationship: Diagnostic Relevance to Multiple Diseases Including COVID-19
Current Pharmaceutical Biotechnology QSAR and Docking Studies of HCV NS3 Serine Protease Inhibitors
Medicinal Chemistry Biomarkers for Risk Assessment and Prevention of Breast Cancer
Current Cancer Drug Targets Macrolides in Community-Acquired Pneumonia: The Importance of the Non-Antimicrobial Effect
Current Respiratory Medicine Reviews Targeting Histone Deacetylase Inhibitors for Anti-Malarial Therapy
Current Topics in Medicinal Chemistry Synthesis, Antiproliferative Activity and Molecular Docking of New Thiazole/Benzothiazole Fused Pyranopyrimidine Derivatives
Letters in Organic Chemistry Withdrawal Notice: S.A.R.S Covid-19 A Medicinal Chemistry Approach
Mini-Reviews in Medicinal Chemistry Preface
Reviews on Recent Clinical Trials Resveratrol Ameliorates LPS-induced Acute Lung Injury Mouse Model via Induction of Tristetraprolin
Combinatorial Chemistry & High Throughput Screening The Metabolism of Anticancer Drugs by the Liver: Current Approaches to the Drug Development Process
Current Drug Metabolism Fibroblast Growth Factor Receptor Inhibitors
Current Pharmaceutical Design Effect of Stilbene and Chalcone Scaffolds Incorporation in Clofibric Acid on PPARα Agonistic Activity
Medicinal Chemistry Damage-Associated Molecular Patterns – Emerging Targets for Biologic Therapy of Childhood Arthritides
Inflammation & Allergy - Drug Targets (Discontinued) Periodic Mesoporous Organosilicas as Catalysts for Organic Reactions
Current Organic Chemistry Defining Vulnerable Patients with Heart Failure: Opportunistic Lessons from Covid-19
Current Cardiology Reviews Impact of the Vaccination Against COVID-19 on Frontline Health Workers
Current Drug Safety Computational Methods for Predicting ncRNA-protein Interactions
Medicinal Chemistry Convalescent Plasma Therapy against COVID-19: An Update on the Changing Facets of the ongoing Pandemic
Current Pharmaceutical Biotechnology